Our team is committed to helping local residents achieve lasting results, empowering you to lead a healthier, happier life
The role of SGLT2i in diabetic HFpEF SGLT2i, a class of the most recent anti-hyperglycemic drugs, have demonstrated beneficial effects on cardiovascular outcomes and played an important role in DM patients with HFpEF (Table 2)
This is especially important for medications with narrow therapeutic windows, such as warfarin, levothyroxine, and certain oral contraceptives
Proper dosing maximizes treatment efficacy and safety, which is especially important as semaglutide can significantly assist with weight reduction, improve blood sugar management, and reduce the risk of severe cardiovascular incidents in adults with type 2 diabetes and existing cardiovascular issues
With therapies that are more effective and target multiple aspects of the bodys weight-regulation system, we are entering a new era in the fight against obesity